Delivery Order SPE2DB24D2013-SPE2DB25FCJSF
Award Date 7/23/25
Potential Completion Date 7/24/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 MG tablets (30-count units) with a ceiling value of $1,830.53. This firm fixed-price delivery order, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of XCOPRI 50 MG tablets (30-count packages) valued at $7,622.85. This firm fixed-price delivery order represents a non-competitive award and carries an ultimate completion date of August 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count units) with a ceiling value of $7,208.56. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive award and was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.96 delivery order contract is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance ending on June 12, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $1,497.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.96 firm fixed-price delivery order is for the supply of the pharmaceutical product XCOPRI 100 MG TABLET 30S, with a completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $1,244.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 150 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,822.30 firm-fixed-price delivery order contract covers the supply of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with a performance period through March 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- The Defense Logistics Agency awarded a delivery order valued at $3,536.88 to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count units) under a firm fixed price contract. The award was made on July 30, 2025, with a completion date of July 31, 2025, and performance will be executed at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, reflecting the vendor's established capability to meet federal...